+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report

  • Report
  • June 2026
  • 504 Pages
  • Global
From
Autoimmune Disease Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Autoimmune Disease Therapeutics - Global Strategic Business Report

  • Report
  • June 2026
  • 368 Pages
  • Global
From
Psoriasis Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Psoriasis Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 185 Pages
  • Global
From
Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 177 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 186 Pages
  • Global
From
Inflammatory Bowel Disease (IBD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Inflammatory Bowel Disease (IBD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • November 2025
  • 190 Pages
  • Global
From
Psoriatic Arthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Psoriatic Arthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • September 2025
  • 185 Pages
  • Global
From
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • June 2025
  • 185 Pages
  • Global
From
Systemic Juvenile Idiopathic Arthritis Market Report 2026 - Product Thumbnail Image

Systemic Juvenile Idiopathic Arthritis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Psoriasis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment - Global Strategic Business Report

  • Report
  • June 2026
  • 566 Pages
  • Global
From
COSENTYX Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

COSENTYX Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Tocilizumab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Tocilizumab Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Psoriasis Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Thumbnail Image

Psoriasis Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Thumbnail Image

Ulcerative Colitis Market Report by Type, Disease Type, Molecule Type, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • April 2026
  • 150 Pages
  • Global
From
Rheumatoid Arthritis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Rheumatoid Arthritis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 120 Pages
  • Global
From
Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update (2025) - Product Thumbnail Image

Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis - Update (2025)

  • Report
  • August 2025
  • 118 Pages
  • Global
From
Psoriasis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Psoriasis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • September 2025
  • 205 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more